首页> 外国专利> Triphenylethylene derivatives similar to tamoxifen or toremifene derivatives

Triphenylethylene derivatives similar to tamoxifen or toremifene derivatives

机译:与他莫昔芬或托瑞米芬衍生物相似的三苯基乙烯衍生物

摘要

A compound of Formula I and compositions thereof for the treatment or prevention of arthritic diseases, breast cancer or cardiovascular disease. Wherein; R1 is -(CH2)nCR5=CR6R7, -(CH2)mC(X)NR8R9 or Formula II; R2 -CH3, OH, OCH3, -OCH2CH3 or -CH(CH3)2; R3 H, -CH3, OH, OCH3, -OCH2CH3 or -CH(CH3)2; R4 is -CN, -NO2, -CH3, -CH2CH2-Y or -Y; R5 and R6 are independently H, -C1-4alkyl, -C2-4alkenyl, -C2-4alkynyl, -X-C1-3alkyl, -X-C2-4alkenyl, -X-C2-4alkynyl or -Y; R7 is -CN, -C1-4alkyl-OH, -C(O)NR10R11, -C(O)NR12R13, -C1-4alkyl-NR10R11, -C(O)R12, -C(O)OR12, -C(O)NR12OR13, -C(O)NHC(O)R12, -C(O)NHCH2R12, -S(O)(O)(OR12), -S(O)(O)(NHCO2R12), PO3R12, -P(O)(NR12R13)(NR12R13), -P(O)(NR12R13)(OR14), -CONR12(CH2)qOCH3, -CONR12(CH2)qNR3R9 or oxadiazole substituted with methyl; R8 and R9 are independently hydrogen, -C1-7alkyl, -C3-7cycloalkyl, -O-C1-7alkyl, C1-7alkyl-Y or phenyl; R10 and R11 are independently methyl or ethyl or, taken together form a morpholino group bonded via its nitrogen atom; R12, R13 and R14 are independently H, -C1-12alkyl, -C2-12alkenyl, -C2-12alkynyl, -O-C1-12alkyl, -O-C2-12alkenyl, -O-C2-12alkynyl, C3-7cycloalkenyl, -C3-7cycloalkenyl linear and cyclic heteroalkyl, aryl, heteroaryl or -Y; X is oxygen or sulphur; Y is a halogen; n is an integer selected from 0, 1 or 2; m is an integer 1 or 2; p is an integer selected from 1-4; and q is an integer from 1-12.
机译:式I的化合物及其组合物,用于治疗或预防关节炎,乳腺癌或心血管疾病。其中R1是-(CH2)nCR5 = CR6R7,-(CH2)mC(X)NR8R9或式II; R 2 -CH 3,OH,OCH 3,-OCH 2 CH 3或-CH(CH 3)2; R 3 H,-CH 3,OH,OCH 3,-OCH 2 CH 3或-CH(CH 3)2; R4为-CN,-NO2,-CH3,-CH2CH2-Y或-Y; R5和R6独立地为H,-C1-4烷基,-C2-4烯基,-C2-4炔基,-X-C1-3烷基,-X-C2-4烯基,-X-C2-4炔基或-Y; R7为-CN,-C1-4烷基-OH,-C(O)NR10R11,-C(O)NR12R13,-C1-4烷基-NR10R11,-C(O)R12,-C(O)OR12,-C( O)NR12OR13,-C(O)NHC(O)R12,-C(O)NHCH2R12,-S(O)(O)(OR12),-S(O)(O)(NHCO2R12),PO3R12,-P (O)(NR12R13)(NR12R13),-P(O)(NR12R13)(OR14),-CONR12(CH2)qOCH3,-CONR12(CH2)qNR3R9或被甲基取代的恶二唑; R 8和R 9独立地是氢,-C 1-7烷基,-C 3-7环烷基,-O-C 1-7烷基,C 1-7烷基-Y或苯基; R10和R11独立地是甲基或乙基,或一起形成通过其氮原子键合的吗啉代基团; R 12,R 13和R 14独立地为H,-C 1-12烷基,-C 2-12烯基,-C 2-12炔基,-O-C 1-12烷基,-O-C 2-12烯基,-O-C 2-12炔基,C 3-7环烯基,- C3-7环烯基直链和环状杂烷基,芳基,杂芳基或-Y; X是氧或硫; Y是卤素; n是选自0、1或2的整数; m是1或2的整数; p是选自1-4的整数; q是1到12之间的整数。

著录项

  • 公开/公告号NZ502625A

    专利类型

  • 公开/公告日2002-04-26

    原文格式PDF

  • 申请/专利权人 GLAXO WELLCOME INC;

    申请/专利号NZ19970502625

  • 发明设计人 WILLSON TIMOTHY MARK;

    申请日1997-08-12

  • 分类号C07C233/11;C07C327/44;C07C69/618;C07C57/42;C07C255/07;C07C251/40;C07C211/28;C07C33/28;C07D271/06;A61K31/165;A61K31/135;

  • 国家 NZ

  • 入库时间 2022-08-22 00:44:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号